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A b s t r a c t 
Viral infections are extremely complex processes that could only be well understood by 
precisely characterizing the interaction networks between the virus and the host components. 
In recent years, much effort has gone in this direction with the aim of unveiling the molecular 
basis of viral pathology. These networks are mostly formed by viral and host proteins, and are 
expected to be dynamic both with time and space (i.e., with the progression of infection, as 
well as with the virus and host genotypes; what we call plastodynamic). This largely 
overlooked spatio-temporal evolution urgently calls for a change both in the conceptual 
paradigms and experimental techniques used so far to characterize virus-host interactions. 
More generally, molecular plasticity and temporal dynamics are unavoidable components of 
the mechanisms that underlie any complex disease; components whose understanding will 
eventually enhance our ability to modulate those networks with the aim of improving disease 
treatments. 
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Viral genomes have very limited coding capacity, and to complete their infectious cycles, 
viral factors (both nucleic acids and proteins) must target, directly or indirectly, many host 
elements. However, the interaction networks established between virus and host factors are 
poorly understood, and only in recent years they have been approached with the use of 
different experimental and computational techniques [1,2,3]. The construction of a molecular 
model that captures such virus-host interactions, as well as all interactions underlying the 
physiology of the host cell, is indeed the cornerstone of the emerging discipline of Systems 
Virology [4–7]. With this type of models in hand, it would be possible to reveal the molecular 
basis of disease [8], i.e., to understand how the virus reprograms the cell resources for its own 
benefit, and to deter-mine what counteractions viruses do to avoid host defenses [9,10]. 
Knowing where the virus-host interactions are located within these networks and what 
functions are being perturbed could clarify, on the one hand, general modes of viral action 
and, on the other hand, specific strategies of response against infection by the host cell. It is 
therefore expected that, in the coming years, large-scale screening techniques allow 
expanding considerably the list of interactors for different viruses, showing a more accurate 
and integrated description of viral pathogenesis at the molecular level. 
 
However, most of the work has been (and is being) focused on characterizing a static picture 
of the virus-host interaction, although some pioneering attempts have addressed the dynamic 
properties of these interactions [11,12], also for other relevant diseases like cancer [13]. In-
deed, interactions must dynamically change during the course of disease, and also among 
genetically heterogeneous host individuals. This is particularly serious for the case of 
infectious diseases, for which both the cell and the causing agent evolve during infection. 
Here, we introduce the term plastodynamic interactome (Fig. 1) to define the changes that a 
given protein interaction network experiments. These changes are an unavoidable 
consequence of, at least, three factors: (i) the dynamic nature of the host cell physiology and 
the virus life cycle, due to regulatory circuits at the molecular level, (ii) the fast evolution of 
viral genomes that results from a highly-efficient and error-prone polymerase, and (iii) genetic 
and developmental differences among individual hosts. Arguably, plasticity arises from 
contextual changes, either in form of expression regulation or structural modification, due to 
time or space, that impinge on the activity of the corresponding proteins, then remodeling the 
interactome [13]. Certainly, the plastodynamic nature of virus-host interactomes has not been 
tackled in a comprehensive way so far, despite having a deep impact in pathology and the 
emergence of diseases. Note that nothing prevents the ap-plication of the concept to other 
diseases, not necessarily of infectious etiology. 
 
Firstly, it is clear that as long as the virus infects the host organism, it differentially expresses 
and rearranges its components to maximize its fitness, as it is the case, e.g., of the Human 
immunodeficiency virus (HIV). There, early and late transcriptional phases were identified, 
where small messenger RNAs were first synthesized [14]. This undoubtedly ends in a 
temporal program of the HIV proteome. The available proteins of the host cell to interact with 
the virus can also change throughout infection time, either due to differential expressions or 
post-translational modifications. For instance, as HIV progresses, the Vif protein induces the 
phosphorylation multiple host factors, leading to proteasomal degradation of immune-
response proteins like APOBEC3C or PPP2R5A [12]. It is thus expected some variation in 
the virus-host interactome with time. We can distinguish between variations in short times, 
i.e., days or weeks post-infection, and variations in longer times, i.e., once the virus has 
colonized the whole organism. Secondly, mutations in the viral genome generally result in 
alterations in virus fitness [15,16,17]. RNA viruses use error-prone polymerases to produce 
very large progeny populations, allowing the generation of huge amounts of genetic 
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variability in short periods of time, generally known as viral quasispecies [18]. This may 
result in a series of mutated viral proteins with differences in activity. It is presumed that the 
do-mains affected by these mutations, even by a single amino acid replace-ment, impaired 
their ability to interact with their host partners. This is the case, e.g., of the Hepatitis C virus 
nonstructural protein 5A, where a single mutation can drastically impair the virus replication 
by disrupting the interaction with the human protein FKBP8 [19]. With some mutations, viral 
proteins may however gain new partners. Thirdly, the presence of a common virus in different 
hosts (even hosts of the same species but with different genotypes) will result in partially 
different virus-host interactomes, since the host proteins may differ in sequence and present a 
high degree of plasticity in their binding ability [20,21]. A differential level of expression of 
the very same protein among hosts could also matter in the establishment of a given 
interaction [22]. Moreover, environmental effects that affect the host physiology could also be 
included in this picture as a source of non-genetic variability among hosts. In sum, this 
plethora of interactions between highly polymorphic and evolvable viral populations and 
genetically di-verse and plastic hosts has obvious impact to understand the emergence and 
epidemiology of viral infections. 
 
Even though, a precise understanding of the virus-host interplay goes beyond capturing 
protein interactions between virus and host factors, even beyond capturing the plastodynamic 
nature of such interactions. On the one hand, we would need to simultaneously retrace the 
mechanisms by which changes in the virus-host interactome occur. This is clearly due to a 
fine-tuned and highly-wired host regulatory circuitry, which can still be manipulated by the 
virus. Whilst defense genes are transcriptionally activated upon virus entry into the cell [23], 
post-translational modifications such as ubiquitination/SUMOylation [24] or phosphorylation 
[12] are strategies that viruses employ to remodel cell signaling with the aim of maximizing 
their fitness. On the other hand, we would need to take into account the subcellular 
localization of the virus-host protein complexes. This information is instrumental to determine 
with precision the mode of action of the virus, including its replication [19] and its movement 
through the host [25], and ultimately resolve the pathological outcome of infection. 
 
To assess the changes in virus-host protein interactomes due to infection progression, virus 
diversity, and host range and plasticity, two different but complementary experimental 
approaches would be required. One approach consists of protein complementation assays, 
e.g., yeast two-hybrid (Y2H) [26], the most commonly used technique. In these assays, the 
potential interaction is decontextualized, which can present some limitations, but offers a 
sensitive and cost-effective mean to screen a library of proteins fragments prepared from the 
de-sired cell types, tissues or entire organisms against a viral protein of interest. Y2H has led 
to the distillation of multiple protein interactomes, including the construction of a 
comprehensive virus-host interactome for two members of the family Herpesviridae [3]. The 
cellular decontextualization of interactions associated to the Y2H technique can in part be 
overcome by the use of bimolecular fluorescence complementation (BiFC) [27], which allows 
identifying protein-protein inter-actions in the real host cell, and also provides valuable 
information about subcellular localization of the complexes and its potential change during 
the course of infection. Unfortunately, this technique is hard to scale up to allow for high-
throughput analyses of hundreds (or even thousands) of potential interactions. The other 
approach consists of protein purification assays, either by co-immunoprecipitation (co-IP) 
[28], provided the availability of a suitable antibody, by affinity purification (AP) of properly 
tagged proteins [29], or by intact cell labeling with chemical cross-linkers, the protein 
interaction reporters (PIRs) [30], followed by mass spectrometry (MS). These techniques 
offer a high-throughput way of capturing, from cell extracts, all proteins that inter-act in form 
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of complexes with the viral protein thanks to mass spectroscopy. In particular, AP-MS has 
allowed the construction of the global interactome of HIV [31], and also the identification of 
the host targets of some plant virus proteins during real infection [32]. The PIR technol-ogy 
has also allowed the identification of host targets for a plant virus, but has additionally 
provided valuable information on the structural do-mains involved in the interactions [33]. 
The future use of recently developed protein microarrays also constitutes a plausible strategy 
for the discovery of virus-host interactions at a large scale [34]. Protein purification followed 
by MS appears hence suitable to analyze in a high-throughput way the interactome along the 
three dimensions, although at the cost of having false positives. However, protein 
complementation seems constrained to only explore in a high-throughput way the dimension 
of virus genotype. In this regard, gene expression profiling at different times of infection 
could help to interpret in a dynamic way protein-protein interaction data [35]. Certainly, an 
integrative analysis of multi-omic data would be required to accurately assess the 
plastodynamic nature of virus-host interactions, and ultimately compose a detailed model of 
viral infection [7]. 
 
In sum, the information resulting from this type of studies would allow explaining different 
stages of infection, and also different susceptibilities between individuals, with applications 
from personalized medicine to epidemiology [36]. This would also be a valuable framework 
to shed light on the intricate mechanisms that operate during the virus-host coevolution [20], 
as it would help to identify commonalities and specificities of interactions that arise after 
genetic diversification (of vi-ruses and hosts) in scenarios of colonization and of adaptation to 
new hosts [37,38]. In this sense, it might serve to study emerging infectious diseases. In 
addition, it would ground the foundations to develop in the mid-term future new effective 
antiviral therapies that either block the interaction of a viral protein with an essential cellular 
target at a precise time (according to the infection progression state), or, alternatively, 
interfere at a given point of the cellular network (perhaps tightly host specific) to counteract 
the effect of the viral quasispecies [39,40]. The potential development of such therapies, 
which would limit side effects on cell physiology and viral escapes, is especially relevant in 
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Fig. 1. Scheme of the plastodynamic virus-host interactome. The protein interactome can vary 
with time (i.e., as long as the virus infects the organism), with the sequence of the virus that 
codes for interacting proteins (this has a short-term effect as viruses are replicated by error-
prone polymerases, and a long-term effect for the emergence of new strains), and finally with 
the host (as different genotypes will deploy different proteomes with particular interaction 
abilities). 
 
 
